Related Experiment Video
Updated: Aug 8, 2026
07:54
Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Extreme hyperbilirubinemia in newborn infants
Filiz Tiker1, Hande Gulcan, Hasan Kilicdag
1Department of Pediatrics, Division of Neonatology, Baskent University Faculty of Medicine, Adana, Turkey.
Clinical Pediatrics
|May 19, 2006
Summary
Extreme hyperbilirubinemia (total serum bilirubin [TSB] ≥ 25 mg/dL) affected 12% of admitted neonates in Turkey. In most cases, the cause of severe newborn jaundice remained unidentified.
Area of Science:
- Neonatal Medicine
- Pediatrics
- Clinical Chemistry
Background:
- Extreme hyperbilirubinemia, defined as total serum bilirubin (TSB) ≥ 25 mg/dL, is a significant concern in newborns.
- Identifying the etiology of severe newborn jaundice is crucial for timely intervention and preventing complications.
Purpose of the Study:
- To determine the frequency of extreme hyperbilirubinemia in neonates admitted to a neonatal intensive care unit.
- To investigate the potential causes of extreme hyperbilirubinemia in this population.
Main Methods:
- Retrospective chart review of term and near-term infants admitted with TSB ≥ 25 mg/dL within the first 30 days of life.
- Analysis of demographic data, feeding methods, and laboratory results including glucose-6-phosphate dehydrogenase deficiency and thyroid function tests.
Main Results:
- Ninety-three out of 774 (12%) infants admitted over 4.5 years had extreme hyperbilirubinemia (mean TSB 30.1 mg/dL).
- The majority of infants (89/93) were exclusively breast-fed.
- Identified causes included isoimmunization (19), bacteremia (7), glucose-6-phosphate dehydrogenase deficiency (2/39), and hypothyroidism (1/71).
Conclusions:
- Extreme hyperbilirubinemia occurs in a notable percentage of neonates requiring NICU admission.
- In over 65% of cases, the specific etiology for severe newborn jaundice could not be identified despite investigations.
- Further research is needed to elucidate the causes of unexplained extreme hyperbilirubinemia in newborns.
Related Concept Videos
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...